Surgical correction of initial CHP is successful

Article

Compensatory head posture is reversed after Anderson-Kestenbaum surgery.

Compensatory head posture is reversed after Anderson-Kestenbaum surgery, according to a paper in the European Journal of Ophthalmology.

Dr Silay Canturk Ugurbas et al., Department of Ophthalmology, Zonguldak Karaelmas, University Faculty of Medicine, Turkey, conducted a retrospective chart review on four patients with cogenital nystagmus. The participants presented with a new version of their original horizontal compensatory head posture (CHP) or a reversal of CHP after Anderson-Kestenbaum surgery.

At the time of initial surgery, all patients had a 40–45° horizontal face turn and to correct the CHP three patients underwent 20% and one experienced 30% augmented A-K surgery. Reversal of the original CHP was recorded for an average of four years postoperatively.

The results showed that the reversed CHPs measured 20°, 40°, 20° and 20°, respectively. In all patients an acceptable head position was achieved and in three patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.